Table 1

Patient and tumor characteristics

CharacteristicsMedian (range), n (%)
All cases, n10
Age, year63.5 (46–74)
BMI (kg/m2)30.0 (21.5–40.1)
Platinum-free interval (months)24 (17–145)
Pre-operative CA125 (U/mL)43 (7–1292)
Cytoreduction status
 Secondary8 (80%)
 Tertiary2 (20%)
FIGO stage at diagnosis
 IIC1 (10%)
 IIIB2 (20%)
 IIIC6 (60%)
 IV1 (10%)
Histopathologic subtype
 Serous8 (80%)
 Granulosa cell1 (10%)
 Malignant mixed Müllerian tumor (MMMT)1 (10%)
Tumor grade
 11/10 (10%)
 2 or 39/10 (90%)
Status of primary debulking
 R09 (90%)
 R1–21 (10%)
Status post-splenectomy
 R010 (100%)
Recurrence post-splenectomy
 Yes5/10 (50%)
 No5/10 (50%)
  • BMI, body mass index; CA125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics; R0, resection for cure or complete remission; R1, resection to microscopic residual tumor; R2, resection to macroscopic residual tumor.